This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat ...
Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its ...
Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII. If you ...
Purpose: To confirm the feasibility and estimate the efficacy of methotrexate (MTX), teniposide, carmustine, and methylprednisolone (MBVP) chemotherapy combined with radiotherapy (RT) for patients ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Methotrexate Injection is used in the treatment of multiple conditions, including various cancers such as acute lymphoblastic ...
Researchers develop targeted polymersomes to enhance methotrexate delivery, offering a promising new approach for treating aggressive choriocarcinoma. Study: ENT-1-Targeted Polymersomes to Enhance the ...
Alembic Pharmaceuticals secures USFDA approval for generic Methotrexate injection, boosting its oncology portfolio and strengthening its presence in the US generics market.
Alembic Pharmaceuticals receives USFDA approval for a generic methotrexate injection used in treating cancer and arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results